These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 13667225)
1. [Blood pictures in cancerous diseases]. BROYE M Oncologia; 1959; 12(2):78-9. PubMed ID: 13667225 [No Abstract] [Full Text] [Related]
2. [Investigation of a catalase inhibitor in the plasma of cancerous and non-cancerous individuals]. PLAZA DE LOS REYES M; MARTENS J; BRADFORD I; MERINO I Rev Med Chil; 1955 Mar; 83(3):185-8. PubMed ID: 14395826 [No Abstract] [Full Text] [Related]
3. [Pentolytic power of cancerous serum]. PELEMAN G C R Seances Soc Biol Fil; 1953 Apr; 147(7-8):724-6. PubMed ID: 13107233 [No Abstract] [Full Text] [Related]
4. [Blood mucoproteins in various cancerous states]. INFANTE MIRANDA F Rev Clin Esp; 1955 Apr; 57(2):81-7. PubMed ID: 14395706 [No Abstract] [Full Text] [Related]
5. [Exsistence of a specific substance in the blood of cancerous patients & its possible therapeutic use]. ESCULIES J Dia Med; 1958 Sep; 30(68):2494-6. PubMed ID: 13586132 [No Abstract] [Full Text] [Related]
6. [Level of free choline in blood serum in cancerous patients]. TSIELENS EA; SKARDE IK Vopr Klin Lecheniia Zlokachestvennykh Novoobraz; 1956; 4():209-14. PubMed ID: 13468314 [No Abstract] [Full Text] [Related]
7. [Effect of time of contact with urea on aggregation of proteins of normal and cancerous human sera]. SANTAMARIA R; MATTACE RASO F Boll Soc Ital Biol Sper; 1957; 33(8-9):1234-7. PubMed ID: 13522890 [No Abstract] [Full Text] [Related]
8. [Diagnostic significance of erythrocyte diameter change in cancerous new growths]. KHOKHLOV LI Vopr Onkol; 1959; 5(6):699-706. PubMed ID: 13676428 [No Abstract] [Full Text] [Related]
9. [Studies of the pentolytic properties of cancerous serum]. PELEMAN G Rev Med Liege; 1954 Jun; 9(11):336-9. PubMed ID: 13178342 [No Abstract] [Full Text] [Related]
10. [Lipid metabolism. I. Determination of total, free, and esterified cholesterol in blood serum in carcinomas and in liver diseases]. MICHALEC C; KOCNA A; KOTRLIK J Cas Lek Cesk; 1952 Jun; 91(26):767-71. PubMed ID: 14390277 [No Abstract] [Full Text] [Related]
11. Cancer diagnosis by discrimination between normal and malignant human blood samples using attenuated total reflectance-Fourier transform infrared spectroscopy. Khanmohammadi M; Ansari MA; Garmarudi AB; Hassanzadeh G; Garoosi G Cancer Invest; 2007 Sep; 25(6):397-404. PubMed ID: 17882650 [TBL] [Abstract][Full Text] [Related]
12. [Blood glucosamine in various diseases with special consideration of pulmonary tuberculosis]. SUDHOF H; PETROVIC C Dtsch Arch Klin Med; 1955; 202(1):98-106. PubMed ID: 14380000 [No Abstract] [Full Text] [Related]
13. [The serum protein disorders in the malignant blood diseases]. CROIZAT P; CREYSSEL R Rev Prat; 1961 Feb; 11():587-96. PubMed ID: 13696529 [No Abstract] [Full Text] [Related]
14. Polyamines and cancer: minireview article. Bachrach U Amino Acids; 2004 Jul; 26(4):307-9. PubMed ID: 15290334 [TBL] [Abstract][Full Text] [Related]
15. On-chip erythrocyte deformability test under optical pressure. Lee WG; Bang H; Yun H; Lee J; Park J; Kim JK; Chung S; Cho K; Chung C; Han DC; Chang JK Lab Chip; 2007 Apr; 7(4):516-9. PubMed ID: 17389970 [TBL] [Abstract][Full Text] [Related]
16. [Blood coagulability in various hemorrhagic conditions]. PELLO F; VANACORE C Prog Med (Napoli); 1960 Aug; 16():505-23. PubMed ID: 13734015 [No Abstract] [Full Text] [Related]